ABBV: EC Approves SKYRIZI
AbbVie's SKYRIZI is approved by the European Commission for children and adolescents with moderate to severe plaque psoriasis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.